Covid-19 has disrupted supply chains and global logistics as it restricted trade and travel, this also had implications for healthcare.
Salient Advisory in its recent report has outlined how this has led to challenges in access to essential healthcare products like diagnostics and therapeutics an
```
Members Only
Login or create an account to continue
This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.
New to BusinessDay? Register now and start reading.
```
Josephine Okojie-Okeiyi
Josephine Okojie-Okeiyi is a journalist with over five years’ reporting experience. She writes on industry, agriculture, commodities, climate change, and environmental issues.
She is fellow of Thomson Reuters Foundation and Bloomberg Media Initiative for Africa.